日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

一项在越南开展的随机、安慰剂对照1/2期临床试验中,基于鸡蛋培养的表达SARS-CoV-2刺突蛋白的灭活新城疫病毒疫苗的安全性和免疫原性:中期结果

Duc Dang, Anh; Dinh Vu, Thiem; Hai Vu, Ha; Thanh Ta, Van; Thi Van Pham, Anh; Thi Ngoc Dang, Mai; Van Le, Be; Huu Duong, Thai; Van Nguyen, Duoc; Lawpoolsri, Saranath; Chinwangso, Pailinrut; McLellan, Jason S; Hsieh, Ching-Lin; Garcia-Sastre, Adolfo; Palese, Peter; Sun, Weina; Martinez, Jose L; Gonzalez-Dominguez, Irene; Slamanig, Stefan; Manuel Carreño, Juan; Tcheou, Johnstone; Krammer, Florian; Raskin, Ariel; Minh Vu, Huong; Cong Tran, Thang; Mai Nguyen, Huong; Mercer, Laina D; Raghunandan, Rama; Lal, Manjari; White, Jessica A; Hjorth, Richard; Innis, Bruce L; Scharf, Rami

Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination.

接种 CoronaVac 疫苗后长达一年的体液和细胞免疫反应评估

Costa Priscilla Ramos, Correia Carolina Argondizo, Marmorato Mariana Prado, de Carvalho Dias Juliana Zanatta, Thomazella Mateus Vailant, da Silva Amanda Cabral, de Oliveira Ana Carolina Soares, Gusmão Arianne Fagotti, Ferrari Lilian, Freitas Angela Carvalho, Patiño Elizabeth González, Grifoni Alba, Weiskopf Daniela, Sette Alessandro, Scharf Rami, Kallas Esper Georges, Terrassani Silveira Cássia Gisele